Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Periodontal and cariogenic bacteria are a diverse group of microorganisms that inhabit the oral cavity and are the primary etiological agents of dental caries and periodontal diseases. Cariogenic bacteria, such as Streptococcus mutans, thrive in acidic environments and ferment dietary sugars into lactic acid, leading to the demineralization of tooth enamel [1]. In contrast, periodontal bacteria, including Porphyromonas gingivalis and Treponema denticola, are typically anaerobic and reside in subgingival biofilms where they trigger inflammatory responses that destroy the gingiva and alveolar bone [2]. These organisms exist within complex, structured communities known as biofilms, which provide significant resistance against host immune defenses and conventional antimicrobial treatments [3]. Management of these pathogens involves a combination of mechanical debridement, topical antiseptics like chlorhexidine, and systemic or local antibiotics such as metronidazole or doxycycline [4]. Furthermore, chronic oral infections caused by these bacteria have been linked to systemic health issues, including cardiovascular disease and adverse pregnancy outcomes, emphasizing the importance of their control [5].
Antimicrobial agents target these bacteria through various mechanisms, including the inhibition of bacterial cell wall synthesis (e.g., penicillins), disruption of protein synthesis (e.g., tetracyclines), interference with DNA replication (e.g., metronidazole), and the inhibition of bacterial glycolysis and enamel demineralization (e.g., fluoride) [4].
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Periodontal and cariogenic bacteria.